In a recent and concerning development, India’s drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has flagged over fifty medications, including treatments for diabetes, high blood pressure, and bacterial infections, as not meeting quality standards. The alert issued for August designates these drugs as "Not of Standard Quality" (NSQ), raising alarms about the safety of widely used medications.